|
Volumn 10, Issue 4, 1998, Pages 379-381
|
Preparing for HIV vaccines that induce cytotoxic T lymphocytes. Editorial overview
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMINO ACID;
ANTIBODY;
ASPARAGINE;
CROSS REACTING ANTIGEN;
EPITOPE;
GAMMA INTERFERON;
GLYCOPROTEIN GP 120;
HLA A2 ANTIGEN;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
NEUTRALIZING ANTIBODY;
PEPTIDE;
RECEPTOR PROTEIN;
RECOMBINANT DNA;
TETRAMER;
VIRUS ENVELOPE PROTEIN;
AFRICA;
ANTIBODY COMBINING SITE;
CARBOHYDRATE ANALYSIS;
CLINICAL TRIAL;
CRYSTAL STRUCTURE;
CYTOTOXIC T LYMPHOCYTE;
DEVELOPING COUNTRY;
DISEASE COURSE;
EDITORIAL;
ENZYME LINKED IMMUNOSORBENT ASSAY;
GENETIC POLYMORPHISM;
GLYCOSYLATION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS 2;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNE RESPONSE;
LABORATORY TEST;
MACACA;
MUTANT;
NONHUMAN;
RECEPTOR BINDING;
SIMIAN IMMUNODEFICIENCY VIRUS;
SYMPTOMATOLOGY;
VIRUS STRAIN;
|
EID: 0031856337
PISSN: 09527915
EISSN: None
Source Type: Journal
DOI: 10.1016/S0952-7915(98)80107-6 Document Type: Editorial |
Times cited : (4)
|
References (12)
|